NEW YORK ( TheStreet) -- Morningstar (Nasdaq: MORN) hit a new 52-week high Thursday as it traded at $56.41 compared with its previous 52-Week high of $56.33. Morningstar is changing hands at $56.30 with 16,463 shares traded as of 10:26 a.m. ET. Average volume has been 66,100 shares over the past 30 days. Morningstar has a market cap of $2.8 billion and is part of the technology sector and computer software & services industry. Shares are up 4.7% year to date as of the close of trading on Wednesday. Morningstar, Inc. provides independent investment research to investors worldwide. The company operates in two segments, Investment Information and Investment Management. The Investment Information segment offers data, software, and research products and services. The company has a P/E ratio of 38.3, above the average computer software & services industry P/E ratio of 38.1 and above the S&P 500 P/E ratio of 23.3. TheStreet Ratings rates Morningstar as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, expanding profit margins and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had somewhat weak growth in earnings per share. You can view the full Morningstar Ratings Report. See all 52-week high stocks or get investment ideas from our investment research center.
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
More from Markets
Boeing, Airbus and United Technologies - 3 Things to Watch at Paris Air Show
Boeing, Airbus, United Technologies among the big reveals at the 2019 Paris Air Show.
Biotech, Small Cap Speculation Liven Dull Day in Markets
Takeover action in biotech and speculative interest in small caps kept things interesting during an otherwise sleepy Monday, as everyone awaits Wednesday's Fed decision.
Stocks End Slightly Higher in Cautious Trading Ahead of Federal Reserve Meeting
Stocks end moderately ahead as investors are adopting a cautious stance heading into this week's Federal Reserve meeting.
Medical Marijuana Card: Everything You Need to Know
Trying to get a medical marijuana card? Here's what you need to know.
Alibaba Listing Would Brighten a Hong Kong Darkened by Mainland's Clouds
Alibaba Group appears to be prepping a Hong Kong stock offering that could be worth $20 billion, and give a vote of confidence at a time of great tumult.